373 related articles for article (PubMed ID: 10882107)
1. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis.
Glickman MS; Cox JS; Jacobs WR
Mol Cell; 2000 Apr; 5(4):717-27. PubMed ID: 10882107
[TBL] [Abstract][Full Text] [Related]
2. Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence.
Rao V; Gao F; Chen B; Jacobs WR; Glickman MS
J Clin Invest; 2006 Jun; 116(6):1660-7. PubMed ID: 16741578
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of mycobacterial PcaA inhibits mycolic acid cyclopropanation: consequences for intracellular survival and for phagosome maturation block.
Corrales RM; Molle V; Leiba J; Mourey L; de Chastellier C; Kremer L
J Biol Chem; 2012 Jul; 287(31):26187-99. PubMed ID: 22621931
[TBL] [Abstract][Full Text] [Related]
4. Temperature-dependent regulation of mycolic acid cyclopropanation in saprophytic mycobacteria: role of the Mycobacterium smegmatis 1351 gene (MSMEG_1351) in CIS-cyclopropanation of alpha-mycolates.
Alibaud L; Alahari A; Trivelli X; Ojha AK; Hatfull GF; Guerardel Y; Kremer L
J Biol Chem; 2010 Jul; 285(28):21698-707. PubMed ID: 20457615
[TBL] [Abstract][Full Text] [Related]
5. Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis.
Alahari A; Alibaud L; Trivelli X; Gupta R; Lamichhane G; Reynolds RC; Bishai WR; Guerardel Y; Kremer L
Mol Microbiol; 2009 Mar; 71(5):1263-77. PubMed ID: 19183278
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice.
Barkan D; Hedhli D; Yan HG; Huygen K; Glickman MS
Infect Immun; 2012 Jun; 80(6):1958-68. PubMed ID: 22431648
[TBL] [Abstract][Full Text] [Related]
7. The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans-cyclopropane synthetase.
Glickman MS; Cahill SM; Jacobs WR
J Biol Chem; 2001 Jan; 276(3):2228-33. PubMed ID: 11092877
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis.
Huang CC; Smith CV; Glickman MS; Jacobs WR; Sacchettini JC
J Biol Chem; 2002 Mar; 277(13):11559-69. PubMed ID: 11756461
[TBL] [Abstract][Full Text] [Related]
9. Designing novel inhibitors against cyclopropane mycolic acid synthase 3 (PcaA): targeting dormant state of
Verma J; Subbarao N
J Biomol Struct Dyn; 2021 Oct; 39(17):6339-6354. PubMed ID: 32715934
[No Abstract] [Full Text] [Related]
10. Cyclopropanation of α-mycolic acids is not required for cording in Mycobacterium brumae and Mycobacterium fallax.
Brambilla C; Sánchez-Chardi A; Pérez-Trujillo M; Julián E; Luquin M
Microbiology (Reading); 2012 Jun; 158(Pt 6):1615-1621. PubMed ID: 22493302
[TBL] [Abstract][Full Text] [Related]
11. Mycolic acid cyclopropanation is essential for viability, drug resistance, and cell wall integrity of Mycobacterium tuberculosis.
Barkan D; Liu Z; Sacchettini JC; Glickman MS
Chem Biol; 2009 May; 16(5):499-509. PubMed ID: 19477414
[TBL] [Abstract][Full Text] [Related]
12. Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria.
Alahari A; Trivelli X; Guérardel Y; Dover LG; Besra GS; Sacchettini JC; Reynolds RC; Coxon GD; Kremer L
PLoS One; 2007 Dec; 2(12):e1343. PubMed ID: 18094751
[TBL] [Abstract][Full Text] [Related]
13. The changes in mycolic acid structures caused by hadC mutation have a dramatic effect on the virulence of Mycobacterium tuberculosis.
Slama N; Jamet S; Frigui W; Pawlik A; Bottai D; Laval F; Constant P; Lemassu A; Cam K; Daffé M; Brosch R; Eynard N; Quémard A
Mol Microbiol; 2016 Feb; 99(4):794-807. PubMed ID: 26538472
[TBL] [Abstract][Full Text] [Related]
14. The mmaA2 gene of Mycobacterium tuberculosis encodes the distal cyclopropane synthase of the alpha-mycolic acid.
Glickman MS
J Biol Chem; 2003 Mar; 278(10):7844-9. PubMed ID: 12502719
[TBL] [Abstract][Full Text] [Related]
15. Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production.
Dao DN; Sweeney K; Hsu T; Gurcha SS; Nascimento IP; Roshevsky D; Besra GS; Chan J; Porcelli SA; Jacobs WR
PLoS Pathog; 2008 Jun; 4(6):e1000081. PubMed ID: 18535659
[TBL] [Abstract][Full Text] [Related]
16. Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis.
Yuan Y; Lee RE; Besra GS; Belisle JT; Barry CE
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6630-4. PubMed ID: 7604045
[TBL] [Abstract][Full Text] [Related]
17. Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice.
Dubnau E; Chan J; Raynaud C; Mohan VP; Lanéelle MA; Yu K; Quémard A; Smith I; Daffé M
Mol Microbiol; 2000 May; 36(3):630-7. PubMed ID: 10844652
[TBL] [Abstract][Full Text] [Related]
18. Redundant function of cmaA2 and mmaA2 in Mycobacterium tuberculosis cis cyclopropanation of oxygenated mycolates.
Barkan D; Rao V; Sukenick GD; Glickman MS
J Bacteriol; 2010 Jul; 192(14):3661-8. PubMed ID: 20472794
[TBL] [Abstract][Full Text] [Related]
19. The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Identification and functional analysis of CMAS-2.
George KM; Yuan Y; Sherman DR; Barry CE
J Biol Chem; 1995 Nov; 270(45):27292-8. PubMed ID: 7592990
[TBL] [Abstract][Full Text] [Related]
20. Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice.
Bhatt A; Fujiwara N; Bhatt K; Gurcha SS; Kremer L; Chen B; Chan J; Porcelli SA; Kobayashi K; Besra GS; Jacobs WR
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5157-62. PubMed ID: 17360388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
